drugset / Trial / NCT02213081

Ulipristal for Endometriosis-related Pelvic Pain

NCT02213081

Phase 4 Completed 1 enrolled Northwestern University
NaSingle-groupOpen-labelTreatment

Summary

The aim of this research is to assess the benefit of a medication (ulipristal) for alleviation of symptoms in women with chronic, endometriosis-related pelvic pain.

Timeline

Start
2015-02
Primary completion
2016-11
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ulipristal Acetate Unknown 15 mg

Indications